These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8144 related articles for article (PubMed ID: 2257565)
41. Has IL2 a role in the management of minimal residual disease for acute leukemia? Foa R; Meloni G; Guarini A; Mandelli F; Gavosto F Leukemia; 1992 Nov; 6 Suppl 4():92-4. PubMed ID: 1434844 [TBL] [Abstract][Full Text] [Related]
42. The 1st Symposium on Local Cytokine Therapy of Cancer: Interleukin-2, Interferon and Related Cytokines. Hamburg, Germany, 29 April-1 May 1999. Abstracts. Anticancer Res; 1999; 19(3A):1995-2016. PubMed ID: 10498578 [No Abstract] [Full Text] [Related]
43. Engineering an active immunotherapy for personalized cancer treatment and prevention of recurrence. Wu K; Lyu F; Wu SY; Sharma S; Deshpande RP; Tyagi A; Zhao D; Xing F; Singh R; Watabe K Sci Adv; 2023 Apr; 9(17):eade0625. PubMed ID: 37126558 [TBL] [Abstract][Full Text] [Related]
44. Cytokine combinations in immunotherapy for solid tumors: a review. Heaton KM; Grimm EA Cancer Immunol Immunother; 1993 Sep; 37(4):213-9. PubMed ID: 8348559 [TBL] [Abstract][Full Text] [Related]
50. Mechanisms of action and toxicity of immunotherapy with cytokines. Mier JW; Atkins MB Curr Opin Oncol; 1993 Nov; 5(6):1067-72. PubMed ID: 8305541 [TBL] [Abstract][Full Text] [Related]
51. Cancer immunotherapy: imaging assessment of novel treatment response patterns and immune-related adverse events. Kwak JJ; Tirumani SH; Van den Abbeele AD; Koo PJ; Jacene HA Radiographics; 2015; 35(2):424-37. PubMed ID: 25763727 [TBL] [Abstract][Full Text] [Related]
52. [Challenges in Immuno-Oncology - Possibilities for Optimization]. Shimabukuro-Vornhagen A; Subklewe M; von Bergwelt-Baildon M Dtsch Med Wochenschr; 2018 Jul; 143(14):1022-1029. PubMed ID: 30005436 [TBL] [Abstract][Full Text] [Related]
53. Neutrophils in anti-cancer immunological strategies: old players in new games. di Carlo E; Iezzi M; Pannellini T; Zaccardi F; Modesti A; Forni G; Musiani P J Hematother Stem Cell Res; 2001 Dec; 10(6):739-48. PubMed ID: 11798500 [TBL] [Abstract][Full Text] [Related]
54. [Therapeutic use of cytokines]. Kliche KO; Schneider W Versicherungsmedizin; 1993 Aug; 45(4):122-5. PubMed ID: 8379044 [TBL] [Abstract][Full Text] [Related]
55. [Immunotherapy of malignant tumors]. Hermann R Dtsch Med Wochenschr; 1978 Oct; 103(43):1716. PubMed ID: 699803 [No Abstract] [Full Text] [Related]
56. Clinical Application of Cytokines in Pediatric Oncology. Proceedings of a symposium at the XXIII Meeting of the International Society of Pediatric Oncology. Rhodes, Greece, October 1-4, 1991. Med Pediatr Oncol Suppl; 1992; 2():1-39. PubMed ID: 1364000 [No Abstract] [Full Text] [Related]
57. The rationale for current approaches to therapy of malignant neoplasia. Thigpen JT; Clay JC Ala J Med Sci; 1976 Jul; 13(3):252-9. PubMed ID: 984325 [No Abstract] [Full Text] [Related]
58. Interleukin-10: An Immune-Activating Cytokine in Cancer Immunotherapy. Zhang H; Wang Y; Hwang ES; He YW J Clin Oncol; 2016 Oct; 34(29):3576-3578. PubMed ID: 27573656 [No Abstract] [Full Text] [Related]
59. Immunotherapeutic approaches to cancer control. Warner GA AORN J; 1973 May; 17(5):71-4. PubMed ID: 4487487 [No Abstract] [Full Text] [Related]
60. Role of cytokines in cancer treatment. Oncology; 1994; 51(2):122-214. PubMed ID: 8196897 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]